U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, a ...

AstraZeneca (LSE:AZN) recently announced that its investigational antibody, anselamimab, did not achieve statistical ...

AstraZeneca’s anselamimab has failed to show any benefit in patients with light chain amyloidosis in two Phase III trials. A ...

U.S. bank Wells Fargo has suspended all travel to China after one of its employees was barred from leaving the country, ...

Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical ...

AstraZeneca Vietnam has been honoured in the Outstanding CSR Activities category at the 2025 Top 50 Corporate Sustainability ...

Supported by AstraZeneca Malaysia, the initiative uses Us2.AI’s state-of-the-art cardiac ultrasound analysis and was launched ...

In the Phase III CARES trials, anselamimab did not meet the primary endpoint for advanced-stage AL amyloidosis, but a ...

The pound, up 7% this year against the dollar as investors turn away from U.S. assets in response to heightened U.S. policy ...

AstraZeneca AZN reported disappointing results from two late-stage studies that evaluated its investigational light chain ...

New class of Eureka Fellows selected for their outstanding efforts to build a healthier, more equitable world and will receive support to amplify their sustainability impact in Canada and around ...

Following a successful patent defense case upheld by China’s IP authority, AstraZeneca invested nearly 9 billion yuan ($1.24 billion) to establish two global R&D centres in Beijing and Shanghai, said ...